Cullinan Therapeutics, Inc. (CGEM)
10.92
+0.19
(+1.77%)
USD |
NASDAQ |
Jan 14, 09:57
Cullinan Therapeutics EPS Diluted (Quarterly): -0.8567 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.567 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -50.61M |
| Total Expenses (Quarterly) | 50.61M |
| Enterprise Value | 302.48M |
| Earnings Yield | -33.71% |
| Normalized Earnings Yield | -33.71 |